Efforts to identify VDR ligands that are relatively more potent than 1,25D(OH)2D3 in inducing activities in specific tissues or in tumors relative to their ability to induce hypercalcemia have yielded some candidates although all retain the capacity to induce hypercalcemia [35–37]. Here, VDR is linked to hypercalcemia disease.